Healthcare · Healthcare Equipment & Supplies
QVM read Cheap on its own multiples Quality Weak, Valuation Undervalued, Momentum Neutral
Tradinity's own scoring, not a copy of any third party's -- see the Key Metrics section for the real ratios behind each number.
Tradinity's own yes/no questions with the rule stated beside each. “Items without enough data are left out, never counted as a No, and the totals count only answered questions. A summary of numbers on this page, not advice.
PE/EPS use each quarter's real filed EPS only from 45 days after quarter-end (no look-ahead) against the raw close of the day. Price-to-book isn't a mode here: the feed has no dated share count, so there's no real history to chart.
Prices adjusted for splits and bonuses. * = a corporate action affecting this date could not be parsed and is not reflected.
Week = 5 sessions, Month = 22 sessions ending the latest trading day — the same combined NSE+BSE delivery data as the table below, just summed.
Data unavailable (needs at least 2 historical quarters with both a filed EPS and a matching trading day).
Ranks #13 of 13 in Healthcare Equipment & Supplies by market cap -- full peer table on the Financials page.
| Date | Client | Deal | Action | Quantity | Price | Exchange |
|---|---|---|---|---|---|---|
| 10 Dec 2024 | BRIJENDRA KUMAR GUPTA | Bulk | Sell | 37,625 | 103.6800 | BSE |
| 29 Apr 2024 | RAGINI CHETAN MEHTA | Bulk | Sell | 818 | 132.7500 | BSE |
| 29 Apr 2024 | RAGINI CHETAN MEHTA | Bulk | Buy | 27,869 | 135.8900 | BSE |
| 29 Apr 2024 | COUNTER CYCLICAL INVESTMENTS PRIVATE LIMITED | Bulk | Sell | 79,754 | 136.4000 | BSE |
| 23 Apr 2024 | AMIT KUMAR JAIN HUF | Bulk | Buy | 17,056 | 120.2600 | BSE |
| 23 Apr 2024 | AMIT KUMAR JAIN HUF | Bulk | Sell | 27,056 | 117.3800 | BSE |
| 10 Apr 2023 | SANJIV KUMAR GUPTA | Bulk | Sell | 28,121 | 113.9900 | BSE |
| 24 Jan 2023 | AGARWAL KUMAR RAJ | Bulk | Sell | 29,874 | 173.7000 | BSE |
| 28 Dec 2022 | AGARWAL KUMAR RAJ | Bulk | Sell | 29,000 | 103.8500 | BSE |
| 28 Dec 2022 | RAJASTHAN GLOBAL SECURITIES PRIVATE LIMITED | Bulk | Buy | 33,419 | 103.6300 | BSE |
| Ex-date | Subject | Per share (₹) | Record date |
|---|---|---|---|
| 21 Sep 2010 | Annual General Meeting And Dividend Of Rs.1.20 Per Share | 1.2000 | — |
Bonuses, splits, buybacks and other events. Dividends are listed separately above.
| Ex-date | Type | Subject |
|---|---|---|
| 26 Aug 2014 | OTHER | Annual General Meeting |
| 21 Aug 2013 | OTHER | Annual General Meeting |
| 2 Aug 2012 | OTHER | 30th Annual General Meeting |
| 21 Sep 2011 | OTHER | Annual General Meeting |
Quarterly results, AGMs, buybacks and other board-approved business.
| Date | Purpose | Results |
|---|---|---|
| 13 Nov 2014 | Results | Yes |
| 13 Aug 2014 | Results | Yes |
| 5 Jul 2014 | Others | — |
| 30 May 2014 | Results/Dividend | Yes |
| 8 Feb 2014 | Results | Yes |
Exchange disclosures (NSE and BSE), most recent first.
| Date | Category | Announcement |
|---|---|---|
| 28 Sep 2026 | Insider Trading / SAST | GKB Ophthalmics Ltd - 533212 - Closure of Trading Window |
| 16 Jan 2015 | Price movement | Price movement : Significant price movement has been observed in GKB Ophthalmics Limited.. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, had written to the company. GKB Ophthalmics Limited has vide its letter inter-alia stated, "There are no events or information which is pending with us that has bearing on the performance/operation of the Company, which has led to sudden increase in share price." (Source MSE) |
| 12 Dec 2014 | Outcome of Board Meeting | Gkb Ophthalmics Limited has informed the Exchange that the Board of Directors of the company at the meeting held on 13-11-2014 decided to delist the equity shares of the company from Delhi Stock Exchange and Calcullta Stock Exchange. (Source MSE) |
| 10 Dec 2014 | Disclosure under Insider Trading Regulation | Gkb Ophthalmics Limited has submitted the disclosures in respect of the in the shareholding of Mr. Krishna Gopal Gupta (Purchase of 934 shares), in terms of Regulation 13(3) and 13(4) of SEBI (Prohibition of Insider Trading) Regulations, 1992. (Source MSE) |
| 31 Oct 2014 | Postal Ballot Updates | Gkb Ophthalmics Limited has submited to the Exchange the Proceedings of the Postal Ballot held on 27th October 2014 and the Scrutinizer's Report in terms of Clause 35A of Listing Agreement (Source MSE) |
| 29 Oct 2014 | Updates | Gkb Ophthalmics Limited has informed the Exchange that the Trading Window for dealing with equity shares of the Company by the insiders as defined under the SEBI (Prohibition of Insider Trading) Regulations 1992 shall remain closed from 5th November 2014 to 14th November 2014 (both days inclusive) and shall re-open on 17th November 2014. (Source MSE) |
| 20 Oct 2014 | Disclosure under Insider Trading Regulation | Gkb Ophthalmics Limited has informed the Exchange that the details of change in the shareholding of Mrs. Veena Gupta (purchase of 206 equity shares of the company), in terms of Regulation 13(6) of SEBI (Prohibition of Insider Trading) Regulations 1992. (Source MSE) |
| 17 Oct 2014 | Disclosure under Insider Trading Regulation | Gkb Ophthalmics Limited has informed the Exchange the details of change in the shareholding of Mrs. Veena Gupta (puchase of 1000 equity shares) and Ms. Shefali Chawla (purchase of 534 equity shares), in terms of Regulation 13(6) of SEBI (Prohibition of Insider Trading) Regulations 1992. (Source MSE) |
| 8 Sep 2014 | Annual General Meeting Updates | Gkb Ophthalmics Limited has informed the Exchange that the Notice for Postal Ballot is being sent to all the shareholders of the Company, whose names appear in the Register of members / List of Beneficial owners as on 5th September 2014. (Source MSE) |
| 8 Sep 2014 | Annual General Meeting Updates | Gkb Ophthalmics Limited has submited to the Exchange the deails of voting results of the Annual General Meeting of the Company held on 6th September 2014, in terms of Clause 35A of the Listing Agreement. (Source MSE) |
Tradinity's own rule-based read of the real ratios elsewhere on this page -- not a copy of any third party's, and never a forward-looking prediction.
Board of directors and corporate information →
Data unavailable (no single-stock futures or options activity on record for this company).
The price at the top of this page is the last traded price from exchange data; during market hours it refreshes on its own. The Chart & Technicals section has the full price history.
The Financials page has quarterly and annual results, ratios, cash flow and the balance sheet, on a standalone or consolidated basis.
The Ownership section shows the latest shareholding pattern from exchange filings, with promoter, FII, DII and public holdings by quarter.
No. The scores and checklist on this page are rule-based summaries of published figures, not recommendations. Tradinity is not a registered investment adviser.
